Medtronic Makes Investments in Two ICE Catheter Companies

MT Newswires Live06-03

Medtronic (MDT) is making investments in two privately held intracardiac echocardiography catheter companies to support the expansion of its cardiac ablation portfolio, the company said Wednesday.

Financial details of these investments were not disclosed.

The investments include Beluga Medical, a US premarket ICE developer, and CardioACC, an early commercial-stage China-based company, with ICE catheters providing real-time imaging during electrophysiology procedures and expected to be integrated into Medtronic's Affera system, the company added.

Medtronic said the investments support its cardiac ablation business and Affera ecosystem, aimed at improving efficiency and outcomes in treating atrial fibrillation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment